This book gathers present knowledge on the involvement of ABC transporters in drug transport and resistance. Bringing together updated information from an otherwise scattered field of scientific literature, this resource helps researchers in pharmaceutical science in discovering drugs able to counteract multidrug resistance in diseases like cancer. It examines ABC transporters not only at the cancer cell, but also in other important physiological localizations. This book covers these topics as well as the pharmaceutical and medicinal modulation and inhibition of ABC transporters, helping…mehr
This book gathers present knowledge on the involvement of ABC transporters in drug transport and resistance. Bringing together updated information from an otherwise scattered field of scientific literature, this resource helps researchers in pharmaceutical science in discovering drugs able to counteract multidrug resistance in diseases like cancer. It examines ABC transporters not only at the cancer cell, but also in other important physiological localizations. This book covers these topics as well as the pharmaceutical and medicinal modulation and inhibition of ABC transporters, helping pharmaceutical researchers discover drugs to counteract multidrug resistance in diseases like cancer.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Ahcéne Boumendjel is Professor of Medicinal Chemistry at the University of Grenoble School of Pharmacy, France. Jean Boutonnat is an Assistant Professor and Hospital Practitioner at the Grenoble Medical School and Université Joseph Fourier of Grenoble, France. Jacques Robert is Professor and Head of the Laboratory of Pharmacology of Anticancer Agents at Institut Bergonié and Université Victor Segalen Bordeaux 2, France.
Inhaltsangabe
PREFACE ix CONTRIBUTORS xi INTRODUCTION: WHAT IS MULTIDRUG RESISTANCE? 1 Jonathan A. Sheps and Victor Ling PART I ABC PROTEINS: AN OVERVIEW AND DESCRIPTION OF THE STRUCTURE, GENOME, NORMAL TISSUE EXPRESSION, PHYSIOLOGICAL ASPECT, AND MECHANISM OF ACTION 15 1 The P-glycoprotein 170: Just a multidrug resistance protein or a protean molecule? 17 Fabienne Grandjean-Forestier, Christophe Stenger, Jacques Robert, Mireille Verdier, and Marie-Hélène Ratinaud 2 Multidrug resistance-associated protein (MRP/ABCC proteins) 47 Mylène Honorat, Charles Dumontet, and Lea Payen 3 ABCG2: A new challenge in cancer drug resistance 83 Orsolya Polgar, Robert W. Robey, Kin Wah To, John Deeken, Patricia A. Fetsch, and Susan E. Bates PART II ABC PROTEINS AND ONCOLOGY: EXPRESSION, DETECTION, AND IMPLICATION OF ABC PROTEINS IN HEMATOLOGICAL MALIGNANCIES AND SOLID TUMORS 119 4 Expression, detection, and implication of ABC proteins in acute myeloblastic leukemia 121 Ollivier Legrand, Ruo-Ping Tang, and Jean-Pierre Marie 5 ABC proteins and oncology: Expression, detection, and implication of ABC proteins in solid tumors 143 Jean François Bernaudin, Anne Fajac, Jocelyne Fleury-Feith, Khaldoun Kerrou, and Roger Lacave PART III ABC PROTEINS AND PATHOGENIC MICROORGANISMS 177 6 ABC transporters and resistance to antibiotics 179 Serge Michalet and Marie-Geneviève Dijoux-Franca 7 ABC proteins involved in protozoan parasite resistance 195 Bruno Pradines PART IV MULTIDRUG RESISTANCE (MDR) MODULATION THROUGH INHIBITION OF ABC TRANSPORTERS: DESIGN OF INHIBITORS AND MECHANISM OF ACTION 239 8 Reversal agents for P-glycoprotein-mediated multidrug resistance 241 Hamid Morjani and Claudie Madoulet 9 Reversal agents of multidrug resistance mediated by multidrug resistance-associated proteins (MRPs) 261 Ahcène Boumendjel, Anne Florin, and Jean Boutonnat 10 Reversal agents for breast cancer resistance protein (BCRP)-mediated multidrug resistance 289 Jean Boutonnat, Anne Florin, and Ahcène Boumendjel 11 Strategies to overcome drug resistance in acute and chronic leukemias 315 Eric Solary, Vincent Ribrag, and Stéphane de Botton 12 Multidrug resistance reversal in solid tumors 349 Tatiana Bogush and Jacques Robert PART V BIOLOGICAL AND CLINICAL ASPECTS OF MULTIDRUG RESISTANCE: THE ROLE OF THE TRANSPORTERS AT THE MAIN PROTECTION BARRIERS (ABCB1, ABCC1, ABCC2, ABCG2) ON THE BIOAVAILABILITY OF MANY TYPES OF DRUGS AND MEDICATIONS 363 13 ABC superfamily transporters at the human blood-brain barrier 365 Jean-Michel Scherrmann 14 The role of ABC transporters at the intestinal barrier 385 Roos L. Oostendorp, Jos H. Beijnen, and Jan H.M. Schellens 15 Genetic polymorphisms in ABC transporters 411 Leslie W. Chinn and Deanna L. Kroetz PERSPECTIVES 437 INDEX 441
PREFACE ix CONTRIBUTORS xi INTRODUCTION: WHAT IS MULTIDRUG RESISTANCE? 1 Jonathan A. Sheps and Victor Ling PART I ABC PROTEINS: AN OVERVIEW AND DESCRIPTION OF THE STRUCTURE, GENOME, NORMAL TISSUE EXPRESSION, PHYSIOLOGICAL ASPECT, AND MECHANISM OF ACTION 15 1 The P-glycoprotein 170: Just a multidrug resistance protein or a protean molecule? 17 Fabienne Grandjean-Forestier, Christophe Stenger, Jacques Robert, Mireille Verdier, and Marie-Hélène Ratinaud 2 Multidrug resistance-associated protein (MRP/ABCC proteins) 47 Mylène Honorat, Charles Dumontet, and Lea Payen 3 ABCG2: A new challenge in cancer drug resistance 83 Orsolya Polgar, Robert W. Robey, Kin Wah To, John Deeken, Patricia A. Fetsch, and Susan E. Bates PART II ABC PROTEINS AND ONCOLOGY: EXPRESSION, DETECTION, AND IMPLICATION OF ABC PROTEINS IN HEMATOLOGICAL MALIGNANCIES AND SOLID TUMORS 119 4 Expression, detection, and implication of ABC proteins in acute myeloblastic leukemia 121 Ollivier Legrand, Ruo-Ping Tang, and Jean-Pierre Marie 5 ABC proteins and oncology: Expression, detection, and implication of ABC proteins in solid tumors 143 Jean François Bernaudin, Anne Fajac, Jocelyne Fleury-Feith, Khaldoun Kerrou, and Roger Lacave PART III ABC PROTEINS AND PATHOGENIC MICROORGANISMS 177 6 ABC transporters and resistance to antibiotics 179 Serge Michalet and Marie-Geneviève Dijoux-Franca 7 ABC proteins involved in protozoan parasite resistance 195 Bruno Pradines PART IV MULTIDRUG RESISTANCE (MDR) MODULATION THROUGH INHIBITION OF ABC TRANSPORTERS: DESIGN OF INHIBITORS AND MECHANISM OF ACTION 239 8 Reversal agents for P-glycoprotein-mediated multidrug resistance 241 Hamid Morjani and Claudie Madoulet 9 Reversal agents of multidrug resistance mediated by multidrug resistance-associated proteins (MRPs) 261 Ahcène Boumendjel, Anne Florin, and Jean Boutonnat 10 Reversal agents for breast cancer resistance protein (BCRP)-mediated multidrug resistance 289 Jean Boutonnat, Anne Florin, and Ahcène Boumendjel 11 Strategies to overcome drug resistance in acute and chronic leukemias 315 Eric Solary, Vincent Ribrag, and Stéphane de Botton 12 Multidrug resistance reversal in solid tumors 349 Tatiana Bogush and Jacques Robert PART V BIOLOGICAL AND CLINICAL ASPECTS OF MULTIDRUG RESISTANCE: THE ROLE OF THE TRANSPORTERS AT THE MAIN PROTECTION BARRIERS (ABCB1, ABCC1, ABCC2, ABCG2) ON THE BIOAVAILABILITY OF MANY TYPES OF DRUGS AND MEDICATIONS 363 13 ABC superfamily transporters at the human blood-brain barrier 365 Jean-Michel Scherrmann 14 The role of ABC transporters at the intestinal barrier 385 Roos L. Oostendorp, Jos H. Beijnen, and Jan H.M. Schellens 15 Genetic polymorphisms in ABC transporters 411 Leslie W. Chinn and Deanna L. Kroetz PERSPECTIVES 437 INDEX 441
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
